• 1-614-588-8538 (Ext: 101)
  • US Toll Free

Bioactive wound care market
Bioactive Wound Care Market Analysis: By First Line Interactive Dressing (Foams, Alginates, Hydrogel, Hydrocolloids, Collagen); By Second Line Interactive Dressing (Honey, Hydrofiber, Silicon, Silver) - With Forecast (2015 - 2020)
Report Code : HCR 0035
Published: 25 February, 2016   No. of pages: 124

  • Report Description
  • Table of Contents
  • Tables And Figures
  • Customization Options
Normal wound healing processes are ineffective in treating full-thickness acute burn injuries and other chronic wounds such as venous ulcers, pressure ulcers, and diabetic foot ulcers. The advent of bioactive wound dressing technology aims at improving the healing power in these conditions. Bioactive dressings combat microbial infections, thereby controlling infection and fastening the healing process. Besides being cost-effective, the bioactive wound dressings also reduce leakage, pain and odor resulting from the wounds. Bioactive wound care dressings involve different materials like alginates, chitosan, keratin, collagens and hydrocolloids, which take active participation in healing wounds and fighting infections, rather than just shielding wounds from the outside environment. Bioactive Wound care is a very niche market but is estimated to flourish during the forecast period, owing to the increased demand from the patient pool all across the globe.

The Bioactive Wound Care market can be segmented on the basis of the different modes of interaction and by region. The different interaction modes include First-Line Interactive Dressing, consisting of Semi-Permeable Films, Foams, Alginates and others, and Second-Line Interactive Dressing which involves Honey, Hydrofiber, Silicone and Silver. By region, the market can be classified into North America, Europe, APAC and RoW regions.

Bioactive Wound Care Market

North America accounts for the maximum revenue share in the fiscal year ended 2015, followed by Europe and Asia-pacific regions and will continue to be the leading region in Bioactive Wound Care market during the forecast period till 2020. This can be attributed to the higher incidence of chronic and acute wounds as well as the various government healthcare reimbursement policies which further aid in such treatments. Increasing geriatric population in countries such as U.S. and Canada is also one of the major driving factors behind the growth of Bioactive Wound Care market across these regions. The market will slowly expand in Middle East owing to increasing disposable income and effective price control regulations. The primary beneficiary of bioactive wound dressings are the people affected with diabetes, venous leg ulcers and burns. First-Line Interactive Dressing mode of interaction is the most prominent because this treatment process is affordable and treats a varied range of wounds, whereas the Second-Line Interactive Dressing mode is expensive and has specific dressings for specific kind of wounds. The increasing use of stem cells and growth factors will help in further diversification of the market.

The bioactive wound care market is projected to serve a large customer base composed of different population group based on disease and age. The lack of mandatory clinical trials has pushed the market back. The firms existing in the market need to conduct more clinical trials in Europe and Asia for stronger penetration and drive the market towards positive growth.

Major players profiled in the report include:
  • Smith & Nephew,
  • Acelity,
  • Coloplast,
  • Convatec
  • 3M Healthcare.

The methodology for estimating the Bioactive Wound Care market involved the study of utilization of the various bioactive dressing products supply and demand ratio across the various chronic diseases. The segmentations have been mapped to understand various market dynamics. Simultaneously, the companies involved at raw material, manufacturing, integration and distribution level were also studied from the perspective of their product portfolio, geographical presence, annual turnover and other parameters to substantiate the estimations. All these estimations were further validated via a thorough primary research with industry expert.

1. Bioactive Wound Care - Market Overview
2. Executive Summary
3. Bioactive Wound Care - Market Landscape 
   3.1. Market Share Analysis
   3.2. Comparative Analysis
      3.2.1. Product Benchmarking
      3.2.2. End User Profiling
      3.2.3. Patent Analysis
      3.2.4. Top 5 Financials Analysis
4. Bioactive Wound Care - Market Forces
   4.1. Market Drivers
      4.1.1. Rise In Geriatric Population
      4.1.2. High Incidence Of Chronic & Acute Wounds
   4.2. Market Constraints
      4.2.1. Lack Of Clinical Trials Have Dampened The Growth Of The Market
      4.2.1. Poor Reimbursement Policy In Europe
   4.3. Market Challenges
      4.3.1. High Treatment Cost 
      4.3.2.   Slow Adoption Rate In Asia & Europe
   4.4. Attractiveness Of The Industry
      4.4.1. Power Of Suppliers
      4.4.2. Power Of Customers
      4.4.3. Threat Of New Entrants
      4.4.4. Threat Of Substitution
      4.4.5. Threat Of Competition
5. Bioactive Wound Care Market – Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunity Analysis
   5.4. Product / Market Life Cycle Analysis
6. Bioactive Wound Care Market – By Mode Of Interaction
   6.1. First-Line Interactive Dressing
      6.1.1. Semi-Permeable Films
      6.1.2. Foams
      6.1.3. Alginates
      6.1.4. Hydrocolloids
      6.1.5. Hydrogels
      6.1.6. Collagen
   6.2. Second-Line Interactive Dressing
      6.2.1. Honey
      6.2.2. Hydrofiber
      6.2.3. Silicone
      6.2.4. Silver
7. Global Bioactive Wound Care Market - Geographic Analysis
   7.1. Introduction 
   7.2. North America
   7.2.1. Usa
      7.2.2. Canada
   7.3. Europe
      7.3.1. Uk
      7.3.2. Germany
      7.3.3. Spain
      7.3.4. Italy
      7.3.5. France
   7.4. Apac
      7.4.1. China
      7.4.2. Japan
      7.4.3. India
      7.4.4. Australia
   7.5. Row
8. Market Entropy
   8.1. New Product Launches
   8.2. M&As, Collaborations, Jvs And Partnerships
9. Company Profiles (Overview, Financials, Swot Analysis – Top 5 Companies, Developments, Product Portfolio)
   9.1. Smith & Nephew Plc.
   9.2. 3m Corporation
   9.3. Coloplast As
   9.4. Convatec , Inc.
   9.5. Integra Lifesciences Holdings Corp.
   9.6. Acelity L.P., Inc.
   9.7. Molnlycke Healthcare Group
   9.8. Covalon Technologies Ltd.
   9.9. Organogenesis Inc.
   9.10. Paul Hartmann Ag
   9.11. Hollister Wound Care Inc.
   9.12. Derma Sciences Inc.
   9.13. Human Biosciences Inc.
   9.14. B Braun Melsungen Ag
   9.15. Dermarite Industries Llc
   9.16. Medline Industries Inc.
   9.17. Genadyne 
   9.18. Spiracur
*More Than 40 Companies Are Profiled In This Research Report, Complete List Available On Request*
"*Financials Would Be Provided On A Best Efforts Basis For Private Companies"
10. Appendix
   10.1. Abbreviations
   10.2. Sources
   10.3. Research Methodology
   10.4. Bibliography
   10.5. Compilation Of Expert Insights
   10.6. Disclaimer
List of Tables

Table 1. Top Five Financial Analysis for Bioactive Wound Care, by Company, 2014 (%). 
Table 2. Global Bioactive Wound Care Market Revenue, by Mode of Interaction, 2014 - 2020 ($Million)
Table 3. Global Bioactive Wound Care Industry Revenue, by Region, 2014 - 2020 ($Million).
Table 4. North America Bioactive Wound Care Industry Revenue, by Country, 2014 - 2020 ($Million)
Table 5. North America Market Revenue, by Mode of Interaction, 2014 - 2020 ($Million).
Table 6. Europe Market Revenue, by Country, 2014 - 2020 ($Million).
Table 7. Europe Market Revenue, by Mode of Interaction, 2014 - 2020 ($Million).
Table 8. APAC Market Revenue, by Country, 2014 - 2020 ($Million).
Table 9. APAC Market Revenue, by Mode of Interaction, 2014 - 2020 ($Million)
Table 10. Row Bioactive Wound Care Industry Revenue, by Country, 2014 - 2020 ($Million).
Table 11. Row Market Revenue, by Mode of Interaction, 2014 - 2020 ($Million)
Table 12. Market: New Product Launches.
Table 13. Bioactive Wound Care Market: Acquisitions. 
 

List of Figures

Figure 1. Bioactive Wound Care Market Classification, by Mode of Interaction
Figure 2. Global Market Revenue – by Geographic Region (%).
Figure 3. Bioactive Wound Care, Market Share Analysis, 2014 (%).
Figure 4. Patent Filings (2011-2015).
Figure 5. Patent Filings, by Company, 2011-15 (%)
Figure 6. Cost Distribution for Overall Wound Care Treatment (%).
Figure 7. Pricing Trend of Bioactive Wound Dressings, 2014-2020.
Figure 8. Global Bioactive Wound Care Industry, Product/Market Lifecycle Analysis.
Figure 9. Global Bioactive Wound Care Industry Revenue – by Geographic Region (%).
Figure 10. U.S. Bioactive Wound Care Industry Revenue, 2014-2020, ($Million).
Figure 11. Canada Market Revenue, 2014-2020, ($Million).
Figure 12. UK Market Revenue, 2014-2020, ($Million).
Figure 13. Germany Market Revenue, 2014-2020, ($Million).
Figure 14. Spain Market Revenue, 2014-2020, ($Million).
Figure 15. Italy Market Revenue, 2014-2020, ($Million).
Figure 16. France Market Revenue, 2014-2020, ($Million).
Figure 17. China Market Revenue, 2014-2020, ($Million).
Figure 18. Japan Market Revenue, 2014-2020, ($Million).
Figure 19. India Market Revenue, 2014-2020, ($Million).
Figure 20. Australia Bioactive Wound Care Industry Revenue, 2014-2020, ($Million).
Figure 21. Middle East Bioactive Wound Care Industry Revenue, 2014-2020, ($Million).
Figure 22. Middle East Bioactive Wound Care Industry Revenue, 2014-2020, ($Million).
Figure 23. Bioactive Wound Care Industry New Product Launches, 2012-15.
Figure 24. Bioactive Wound Care Market New Product Launches, 2012-15 (%)
Figure 25. Financial Performance, 2010-2014, ($Billion). 
Figure 26. Smith & Nephew PLC.: Total Revenue, by Region, 2014 (%)
Figure 27. Smith & Nephew PLC.: Total Revenue, by Segment, 2014 (%). 
Figure 28. Smith & Nephew PLC.: Advanced Wound Management, by Category, 2014 (%). 
Figure 29. Financial Performance, 2010-2014, ($Billion). 
Figure 30. 3m Corporation: Total Revenue, by Region, 2014 (%)
Figure 31. 3m Corporation: Total Revenue, by Segment, 2014 (%)
Figure 32. Financial Performance, 2010-2014, ($Billion)
Figure 33. COLOPLAST A/S: Total Revenue, by Region, 2014 (%)
Figure 34. COLOPLAST A/S: Total Revenue, by Segment, 2014 (%). 
Figure 35. Financial Performance, 2010-2014, ($Billion). 
Figure 36. CONVATEC Inc: Total Revenue, by Region, 2014 (%). 
Figure 37. CONVATEC Inc: Total Revenue, by Segment, 2014 (%). 
Figure 38. Financial Performance, 2010-2014, ($Million). 
Figure 39. Integra Life sciences Holding Corp: Total Revenue, by Region, 2014 (%). 
Figure 40. Integra Life sciences Holding Corp: Total Revenue, by Segment, 2014 (%). 
Figure 41. ACELITY L.P. Inc.: Total Revenue, by Region, 2014 (%). 
Figure 42. ACELITY L.P. Inc.: Total Revenue, by Segment, 2014 (%). 
Figure 43. Financial Performance, 2010-2014, ($Million). 
Figure 44. Financial Performance, 2010-2014, ($Billion)
Figure 45. Paul Hartmann Ag.: Total Revenue, by Region, 2014 (%). 
Figure 46. Paul Hartmann Ag.: Total Revenue, by Segment, 2014 (%). 
Figure 47. Financial Performance, 2010-2014, ($Million). 
Figure 48. Derma Sciences Inc.: Total Revenue, by Region, 2014 (%). 
Figure 49. Derma Sciences Inc.: Total Revenue, by Segment, 2014 (%). 
Figure 50. Financial Performance, 2010-2014, ($Billion)
Figure 51. B. Braun Melsungen AG: Total Revenue, by Region, 2014 (%). 
Figure 52. B. Braun Melsungen AG: Total Revenue, by Segment, 2014 (%). 

Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports